Liraglutide Attenuates FFA-Induced Retinal Pigment Epithelium Dysfunction via AMPK Activation and Lipid Homeostasis Regulation in ARPE-19 Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083704 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sing-Hua Tsou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402306, Taiwan. Hauptthemen laut MEDLINE: Liraglutide, Retinal Pigment Epithelium, AMP-Activated Protein Kinases, Lipid Metabolism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung Shan Medical University Hospital, National Science and Technology Council of Taiwan, the bilateral project from National Chung Hsing University and Chung Shan Medical University.
Abstract (Originalsprache)
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in the elderly, and it is characterized by oxidative stress, lipid dysregulation, and dysfunction of the retinal pigment epithelium (RPE). A hallmark of AMD is the presence of drusen, extracellular deposits rich in lipids, proteins, and cellular debris, which are secreted by the RPE. These deposits impair RPE function, promote chronic inflammation, and accelerate disease progression. Despite advancements in understanding AMD pathogenesis, therapeutic strategies targeting lipid dysregulation and oxidative damage in RPE cells remain limited. This study evaluated the effects of liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), on free fatty acid (FFA)-induced damage in ARPE-19 cells, a widely used in vitro model of RPE dysfunction. FFA treatment induced lipid droplet accumulation, oxidative stress, and epithelial–mesenchymal transition (EMT), which are processes implicated in AMD progression. Liraglutide significantly reduced lipid droplet accumulation, mitigated oxidative stress, and suppressed EMT, as demonstrated by high-content imaging, immunocytochemistry, and molecular assays. Mechanistic analyses revealed that liraglutide activates AMP-activated protein kinase (AMPK), enhancing lipophagy and restoring lipid homeostasis. Furthermore, liraglutide influenced exosome secretion, altering paracrine signaling and reducing EMT markers in neighboring cells. These findings underscore liraglutide’s potential to address critical mechanisms underlying AMD pathogenesis, including lipid dysregulation, oxidative stress, and EMT. This study provides foundational evidence supporting the development of GLP-1 receptor agonists as targeted therapies for AMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402306, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung 402306, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung 402306, Taiwan.
- Department of Ophthalmology, Chung Shan Medical University Hospital, Taichung 402306, Taiwan.
- Department of Internal Medicine, Division of Endocrinology and Metabolism, Chung Shan Medical University Hospital, Taichung 402306, Taiwan.
- Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402306, Taiwan.
ORCID-Profile: Sing-Hua Tsou, Edy Kornelius, Hui-Chih Hung, Yu-Chien Hung, Chih-Li Lin, Min-Yen Hsu
Förderung
- Chung Shan Medical University Hospital
- National Science and Technology Council of Taiwan
- the bilateral project from National Chung Hsing University and Chung Shan Medical University
- National Chung Hsing University and Chung Shan Medical University
Zitieren
APA
Tsou, S. H., Luo, K. S., Huang, C. N., Kornelius, E., Cheng, I. T., Hung, H. C., Hung, Y. C., Lin, C. L., & Hsu, M. Y. (2025). Liraglutide Attenuates FFA-Induced Retinal Pigment Epithelium Dysfunction via AMPK Activation and Lipid Homeostasis Regulation in ARPE-19 Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083704
Vancouver
Tsou SH, Luo KS, Huang CN, Kornelius E, Cheng IT, Hung HC, et al. Liraglutide Attenuates FFA-Induced Retinal Pigment Epithelium Dysfunction via AMPK Activation and Lipid Homeostasis Regulation in ARPE-19 Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083704
BibTeX
@article{Tsou2025,
author = {Tsou, Sing-Hua and Luo, Kai-Shin and Huang, Chien-Ning and Kornelius, Edy and Cheng, I-Ting and Hung, Hui-Chih and Hung, Yu-Chien and Lin, Chih-Li and Hsu, Min-Yen},
title = {Liraglutide Attenuates FFA-Induced Retinal Pigment Epithelium Dysfunction via AMPK Activation and Lipid Homeostasis Regulation in ARPE-19 Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083704}
}
EUVIMED